LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx ...
Scientists in China achieve the first successful liver support therapy using ex vivo perfusion and a gene-edited pig.
Immunohistochemistry-based molecular subtyping in muscle-invasive bladder cancer: Predicting response to neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Data supports the novel Trans-Arterial Micro-Perfusion (TAMP TM) therapy platform for targeted chemotherapy delivery for the potential to minimize a therapy’s toxicities versus systemic intravenous ...
First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...
A Chinese research team has used a gene-edited pig liver in an extracorporeal perfusion therapy to treat a patient with acute liver failure. The process saved the patient's life and significantly ...
FUJIFILM Biosciences, announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results